Celator Pharmaceuticals (CPXX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CPXX Hot Sheet
Join SI Premium – FREE
Celator Pharmaceuticals (NASDAQ: CPXX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Celator Pharmaceuticals (CPXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates
- Lowe's slashes full-year sales outlook amid DIY spending pressure
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
